Skip to content
PubMed This is a summary of 80 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 80 referenced papers

Top Authors

Hugh G Calkins
Johns Hopkins University
Cynthia A. James
Johns Hopkins University
Brittney A. Murray
Johns Hopkins University
Crystal Tichnell
Johns Hopkins University
Harikrishna S. Tandri
Johns Hopkins University
J. Peter van Tintelen
Utrecht University
Anneline S.J.M. te Riele
University Medical Center Utrecht
Julia Cadrin‐Tourigny
Montreal Heart Institute
Cristina Basso
University of Padua
Domenico Corrado
University of Padua

Top Institutions

Ranked by publications Top 10 institutions
09

Medical University of South Carolina

Charleston, United States

39 papers

References

References (80)
  1. 1

    Desmoplakin mutations with palmoplantar keratoderma, woolly hair and cardiomyopathy.

    Pigors M, Schwieger-Briel A, Cosgarea R, et al.

    Acta dermato-venereologica 2015; (95(3)):337-40 doi:10.2340/00015555-1974.

    PMID: 25227139
  2. 2

    Normalization of Naxos plakoglobin levels restores cardiac function in mice.

    Zhang Z, Stroud MJ, Zhang J, et al.

    The Journal of clinical investigation 2015; (125(4)):1708-12.

    PMID: 25705887
  3. 3

    Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.

    Protonotarios A, Anastasakis A, Panagiotakos DB, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(4)):610-6 doi:10.1093/europace/euv061.

    PMID: 25825460
  4. 4

    Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.

    Sawant AC, Te Riele AS, Tichnell C, et al.

    Heart rhythm 2016; (13(1)):199-207.

    PMID: 26321091
  5. 5

    Combination of palmoplantar keratoderma and hair shaft anomalies, the warning signal of severe arrhythmogenic cardiomyopathy: a systematic review on genetic desmosomal diseases.

    Polivka L, Bodemer C, Hadj-Rabia S

    Journal of medical genetics 2016; (53(5)):289-95 doi:10.1136/jmedgenet-2015-103403.

    PMID: 26399581
  6. 6

    Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms.

    Ellis A, Risk JM, Maruthappu T, Kelsell DP

    Orphanet journal of rare diseases 2015; (10()):126 doi:10.1186/s13023-015-0346-2.

    PMID: 26419362
  7. 7

    Arrhythmogenic Right Ventricular Cardiomyopathy Caused by a Novel Frameshift Mutation.

    Refaat MM, Tang P, Harfouch N, et al.

    Cardiac electrophysiology clinics 2016; (8(1)):217-21.

    PMID: 26920198
  8. 8

    Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.

    Zorzi A, Rigato I, Bauce B, et al.

    Current cardiology reports 2016; (18(6)):57 doi:10.1007/s11886-016-0734-9.

    PMID: 27147509
  9. 9

    Prognosis and Management of Congenital Hair Shaft Disorders without Fragility-Part II.

    Singh G, Miteva M

    Pediatric dermatology 2016; (33(5)):481-7 doi:10.1111/pde.12902.

    PMID: 27293153
  10. 10

    Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

    Akdis D, Brunckhorst C, Duru F, Saguner AM

    Arrhythmia & electrophysiology review 2016; (5(2)):90-101 doi:10.15420/AER.2016.4.3.

    PMID: 27617087
  11. 11

    Cardiocutaneous syndrome (Naxos disease) in a Bangladeshi boy.

    Islam AM, Rahman MT, Chowdhury AH

    Cardiovascular diagnosis and therapy 2016; (6(5)):462-465 doi:10.21037/cdt.2016.03.07.

    PMID: 27747171
  12. 12

    [Genetic diagnostics for cardiomyopathies].

    Czepluch F, Wollnik B, Hasenfuß G

    Deutsche medizinische Wochenschrift (1946) 2017; (142(9)):657-664 doi:10.1055/s-0042-112183.

    PMID: 28454199
  13. 13

    Electrical Storm or Naxos Syndrome in an Adult Causing Recurrent Syncope.

    Maqbool MF, Sajid M, Noeman A

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2017; (27(4)):250-251 doi:2599.

    PMID: 28492156
  14. 14

    Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

    Gupta R, Tichnell C, Murray B, et al.

    The American journal of cardiology 2017; (120(1)):111-117 doi:10.1016/j.amjcard.2017.03.251.

    PMID: 28506445
  15. 15

    Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.

    Cappelletto C, Stolfo D, De Luca A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(FI1)):f20-f29 doi:10.1093/europace/eux093.

    PMID: 28633348
  16. 16

    Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).

    Romero J, Grushko M, Briceño DF, et al.

    Current cardiology reports 2017; (19(9)):82 doi:10.1007/s11886-017-0893-3.

    PMID: 28779285
  17. 17

    A Mal De Meleda patient with severe flexion contractures of hands and feet: A case report in West China.

    Pan Y, Zhao H, Chen A, Huang X

    Medicine 2017; (96(36)):e7972 doi:10.1097/MD.0000000000007972.

    PMID: 28885351
  18. 18

    Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.

    Gilljam T, Haugaa KH, Jensen HK, et al.

    International journal of cardiology 2018; (250()):201-206 doi:10.1016/j.ijcard.2017.10.076.

    PMID: 29107359
  19. 19

    Case of punctate palmoplantar keratoderma type I treated with combination of low-dose oral acitretin and topical salicylic acid and steroid.

    Jo JW, Jeong DS, Kim CY

    The Journal of dermatology 2018; (45(5)):609-612 doi:10.1111/1346-8138.14255.

    PMID: 29500825
  20. 20

    Naxos disease: from the origin to today.

    Li GL, Saguner AM, Fontaine GH

    Orphanet journal of rare diseases 2018; (13(1)):74 doi:10.1186/s13023-018-0814-6.

    PMID: 29747658
  21. 21

    Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?

    Balić A, Bukvić Mokos Z, Marinović B, Ledić Drvar D

    Acta dermatovenerologica Croatica : ADC 2018; (26(1)):68-70.

    PMID: 29782305
  22. 22

    Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

    Wang W, Orgeron G, Tichnell C, et al.

    Journal of the American Heart Association 2018; (7(12)) doi:10.1161/JAHA.118.008843.

    PMID: 29909402
  23. 23

    Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.

    Lie ØH, Dejgaard LA, Saberniak J, et al.

    JACC. Clinical electrophysiology 2018; (4(6)):744-753 doi:10.1016/j.jacep.2018.01.010.

    PMID: 29929667
  24. 24

    Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.

    Vimalanathan AK, Ehler E, Gehmlich K

    Biophysical reviews 2018; (10(4)):973-982 doi:10.1007/s12551-018-0437-0.

    PMID: 29995277
  25. 25

    Impact of dynamic physical exercise on high-risk definite arrhythmogenic right ventricular cardiomyopathy.

    Ruiz Salas A, Barrera Cordero A, Navarro-Arce I, et al.

    Journal of cardiovascular electrophysiology 2018; (29(11)):1523-1529 doi:10.1111/jce.13704.

    PMID: 30080280
  26. 26

    Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?

    Bennett RG, Haqqani HM, Berruezo A, et al.

    Heart, lung & circulation 2019; (28(1)):164-177 doi:10.1016/j.hlc.2018.10.013.

    PMID: 30446243
  27. 27

    Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center.

    Rootwelt-Norberg C, Lie ØH, Dejgaard LA, et al.

    International journal of cardiology 2019; (279()):79-83 doi:10.1016/j.ijcard.2018.12.066.

    PMID: 30638987
  28. 28

    Pain mechanisms in hereditary palmoplantar keratodermas.

    Weinberg RL, Coulombe PA, Polydefkis M, Caterina MJ

    The British journal of dermatology 2020; (182(3)):543-551 doi:10.1111/bjd.17880.

    PMID: 30883689
  29. 29

    Perceptions of genetic variant reclassification in patients with inherited cardiac disease.

    Wong EK, Bartels K, Hathaway J, et al.

    European journal of human genetics : EJHG 2019; (27(7)):1134-1142 doi:10.1038/s41431-019-0377-6.

    PMID: 30903112
  30. 30

    2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

    Towbin JA, McKenna WJ, Abrams DJ, et al.

    Heart rhythm 2019; (16(11)):e301-e372 doi:10.1016/j.hrthm.2019.05.007.

    PMID: 31078652
  31. 31

    Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.

    van Lint FHM, Murray B, Tichnell C, et al.

    Circulation. Genomic and precision medicine 2019; (12(8)):e002467 doi:10.1161/CIRCGEN.119.002467.

    PMID: 31386562
  32. 32

    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.

    Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA

    The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.

    PMID: 32307694
  33. 33

    Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

    Smith ED, Lakdawala NK, Papoutsidakis N, et al.

    Circulation 2020; (141(23)):1872-1884 doi:10.1161/CIRCULATIONAHA.119.044934.

    PMID: 32372669
  34. 34

    Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.

    Corrado D, Perazzolo Marra M, Zorzi A, et al.

    International journal of cardiology 2020; (319()):106-114 doi:10.1016/j.ijcard.2020.06.005.

    PMID: 32561223
  35. 35

    Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.

    Wang W, Tichnell C, Murray BA, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(8)):1270-1278 doi:10.1093/europace/euaa105.

    PMID: 32572458
  36. 36

    Naxos disease - a narrative review.

    Leopoulou M, Mattsson G, LeQuang JA, et al.

    Expert review of cardiovascular therapy 2020; (18(11)):801-808 doi:10.1080/14779072.2020.1828064.

    PMID: 32966140
  37. 37

    Variant NAXOS-Carvajal Syndrome with Rare Additional Features of Systemic Bulla and Brittle Nails: A Case Report and Literature Review.

    Sato T, Okada S, Iwahana T, Kobayashi Y

    Internal medicine (Tokyo, Japan) 2021; (60(7)):1119-1126 doi:10.2169/internalmedicine.5899-20.

    PMID: 33132336
  38. 38

    Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry.

    Gasperetti A, James CA, Cerrone M, et al.

    European heart journal 2021; (42(13)):1231-1243 doi:10.1093/eurheartj/ehaa821.

    PMID: 33200174
  39. 39

    Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility.

    Vahidnezhad H, Youssefian L, Faghankhani M, et al.

    Scientific reports 2020; (10(1)):21622 doi:10.1038/s41598-020-78344-9.

    PMID: 33303784
  40. 40

    Effect of preload reducing therapy on right ventricular size and function in patients with arrhythmogenic right ventricular cardiomyopathy.

    Kalantarian S, Vittinghoff E, Klein L, Scheinman MM

    Heart rhythm 2021; (18(7)):1186-1191 doi:10.1016/j.hrthm.2021.03.018.

    PMID: 33722762
  41. 41

    International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.

    James CA, Jongbloed JDH, Hershberger RE, et al.

    Circulation. Genomic and precision medicine 2021; (14(3)):e003273 doi:10.1161/CIRCGEN.120.003273.

    PMID: 33831308
  42. 42

    Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program.

    Daimee UA, Assis FR, Murray B, et al.

    Heart rhythm 2021; (18(8)):1369-1376 doi:10.1016/j.hrthm.2021.04.028.

    PMID: 33933674
  43. 43

    Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy.

    Zorzi A, Cipriani A, Bariani R, et al.

    Current cardiology reports 2021; (23(6)):57 doi:10.1007/s11886-021-01489-0.

    PMID: 33961139
  44. 44

    Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy.

    Cappelletto C, Gregorio C, Barbati G, et al.

    International journal of cardiology 2021; (334()):58-64 doi:10.1016/j.ijcard.2021.04.069.

    PMID: 33961942
  45. 45

    Arrhythmogenic Cardiomyopathy-Current Treatment and Future Options.

    Migliore F, Mattesi G, Zorzi A, et al.

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132750.

    PMID: 34206637
  46. 46

    Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.

    Corrado D, Zorzi A, Cipriani A, et al.

    Journal of the American Heart Association 2021; (10(18)):e021987 doi:10.1161/JAHA.121.021987.

    PMID: 34533054
  47. 47

    Clinical and Molecular Aspects of Naxos Disease.

    Protonotarios I, Asimaki A, Xylouri Z, et al.

    Heart failure clinics 2022; (18(1)):89-99 doi:10.1016/j.hfc.2021.07.010.

    PMID: 34776086
  48. 48

    Arrhythmogenic right ventricular cardiomyopathy in the pediatric population.

    Cohen MI, Atkins MB

    Current opinion in cardiology 2022; (37(1)):99-108 doi:10.1097/HCO.0000000000000937.

    PMID: 34857718
  49. 49

    Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity.

    Te Riele ASJM, James CA, Calkins H, Tsatsopoulou A

    Frontiers in pediatrics 2021; (9()):750916 doi:10.3389/fped.2021.750916.

    PMID: 34926342
  50. 50

    The 2020 "Padua Criteria" for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice.

    Graziano F, Zorzi A, Cipriani A, et al.

    Journal of clinical medicine 2022; (11(1)) doi:10.3390/jcm11010279.

    PMID: 35012021
  51. 51

    Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.

    Eberly L, Garg L, Vidula M, et al.

    Current treatment options in cardiovascular medicine 2021; (23(10)) doi:10.1007/s11936-021-00943-0.

    PMID: 35082480
  52. 52

    Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy.

    Malik N, Mukherjee M, Wu KC, et al.

    Circulation. Cardiovascular imaging 2022; (15(2)):e013725 doi:10.1161/CIRCIMAGING.121.013725.

    PMID: 35147040
  53. 53

    Carvajal Syndrome- A Variant of Naxos Disease: A Case Report.

    Mandal KD, Shrestha PN, Ghimire A, et al.

    JNMA; journal of the Nepal Medical Association 2022; (60(246)):187-191 doi:10.31729/jnma.7102.

    PMID: 35210635
  54. 54

    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.

    Cadrin-Tourigny J, Bosman LP, Nozza A, et al.

    European heart journal 2022; (43(32)):e1-e9 doi:10.1093/eurheartj/ehac180.

    PMID: 35441664
  55. 55

    Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-Analysis.

    Sharma A, Bosman LP, Tichnell C, et al.

    Circulation. Genomic and precision medicine 2022; (15(3)):e003530 doi:10.1161/CIRCGEN.121.003530.

    PMID: 35579515
  56. 56

    Arrhythmias as Presentation of Genetic Cardiomyopathy.

    Lukas Laws J, Lancaster MC, Ben Shoemaker M, et al.

    Circulation research 2022; (130(11)):1698-1722 doi:10.1161/CIRCRESAHA.122.319835.

    PMID: 35617362
  57. 57

    Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy.

    de Brouwer R, Bosman LP, Gripenstedt S, et al.

    Heart rhythm 2022; (19(10)):1659-1665 doi:10.1016/j.hrthm.2022.05.038.

    PMID: 35688345
  58. 58

    [Arrhythmogenic right ventricular cardiomyopathy : An update].

    Marchetti M, Pascale P, Muller O, Lu H

    Annales de cardiologie et d'angeiologie 2022; (71(4)):223-227 doi:10.1016/j.ancard.2022.08.006.

    PMID: 36089416
  59. 59

    Towards a Better Understanding of Genotype-Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction.

    Vermeer MCSC, Andrei D, Marsili L, et al.

    International journal of molecular sciences 2022; (23(18)) doi:10.3390/ijms231810765.

    PMID: 36142674
  60. 60

    Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.

    Liu J, Chen Z, Hu L, et al.

    The Journal of dermatology 2023; (50(3)):375-382 doi:10.1111/1346-8138.16621.

    PMID: 36317385
  61. 61

    Clinical course of arrhythmogenic right ventricular cardiomyopathy with end-stage heart failure and outcome after heart transplantation.

    Petruescu L, Lebreton G, Coutance G, et al.

    Archives of cardiovascular diseases 2023; (116(1)):9-17 doi:10.1016/j.acvd.2022.10.005.

    PMID: 36609000
  62. 62

    Sport and exercise in genotype positive (+) phenotype negative (-) individuals: current dilemmas and future perspectives.

    Paldino A, Rossi M, Dal Ferro M, et al.

    European journal of preventive cardiology 2023; (30(9)):871-883 doi:10.1093/eurjpc/zwad079.

    PMID: 36929832
  63. 63

    Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care.

    Janzen ML, Davies B, Laksman ZWM, et al.

    CJC open 2023; (5(4)):268-284 doi:10.1016/j.cjco.2023.02.006.

    PMID: 37124966
  64. 64

    Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy.

    Gaine SP, Calkins H

    Biomedicines 2023; (11(4)) doi:10.3390/biomedicines11041213.

    PMID: 37189831
  65. 65

    Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report.

    Lemus Barrios GA, Lopez-Lopez JP, Barbosa-Balaguera S, Correa AM

    ESC heart failure 2023; (10(5)):3190-3194 doi:10.1002/ehf2.14504.

    PMID: 37632291
  66. 66

    Pachyonychia Congenita: Clinical Features and Future Treatments.

    McCarthy RL, de Brito M, O'Toole E

    The Keio journal of medicine 2025; (74(1)):52-60 doi:10.2302/kjm.2023-0012-IR.

    PMID: 37766547
  67. 67

    Recurrent Syncope in a Patient With Arrhythmogenic Right Ventricular Cardiomyopathy.

    Castillo E

    Cureus 2023; (15(9)):e45850 doi:10.7759/cureus.45850.

    PMID: 37881382
  68. 68

    Generation of a CRISPR/Cas9-edited Plakoglobin (JUP) knock-out (JMUi001-A-4) iPSC line to model the cardiac phenotype of arrhythmogenic cardiomyopathy.

    Walz K, Janz A, Klopocki E, Gerull B

    Stem cell research 2023; (73()):103240 doi:10.1016/j.scr.2023.103240.

    PMID: 37995437
  69. 69

    Natural Course of Electrocardiographic Features in Arrhythmogenic Right Ventricular Cardiomyopathy and Their Relation to Ventricular Arrhythmic Events.

    Svensson A, Jensen HK, Boonstra MJ, et al.

    Journal of the American Heart Association 2024; (13(16)):e031893 doi:10.1161/JAHA.123.031893.

    PMID: 39158567
  70. 70

    Naxos Disease and Related Cardio-Cutaneous Syndromes.

    Protonotarios A, Asimaki A, Basso C, et al.

    JACC. Advances 2025; (4(2)):101547 doi:10.1016/j.jacadv.2024.101547.

    PMID: 39877668
  71. 71

    Genotype and cardiac outcome in patients with cardiocutaneous syndrome (Naxos disease variant: Carvajal syndrome).

    Binfadel M, Aleem MU, Alhabdan M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):137 doi:10.1186/s13023-025-03612-8.

    PMID: 40108711
  72. 72

    A Case of Left-Dominant Arrhythmogenic Cardiomyopathy Presenting with Cardiac Arrest.

    Piya S, Jackson A, Coats CJ, Nordin S

    British journal of hospital medicine (London, England : 2005) 2025; (86(3)):1-12 doi:10.12968/hmed.2024.0674.

    PMID: 40135302
  73. 73

    Arrhythmogenic Right Ventricular Cardiomyopathy: Diagnosis, Risk Stratification, and Treatment.

    Kreimer F, Saguner AM, Akin I, et al.

    Deutsches Arzteblatt international 2025; (122(9)):229-234.

    PMID: 40202346
  74. 74

    Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.

    Muller SA, Asatryan B, Gasperetti A, et al.

    Circulation 2025; (152(5)):313-326 doi:10.1161/CIRCULATIONAHA.125.074058.

    PMID: 40525281
  75. 75

    Familial Woolly Hair.

    Singh S, Singh V, Gupta A

    Annals of African medicine 2026; (25(4)):1017-1018 doi:10.4103/aam.aam_223_25.

    PMID: 41190500
  76. 76

    Microbial dysbiosis and foot odor in Nagashima-type palmoplantar keratosis: Improvement with topical benzoyl peroxide.

    Ono N, Ito Y, Aoki S, et al.

    The Journal of investigative dermatology 2026; (146(6)):1586-1595.e5 doi:10.1016/j.jid.2025.11.011.

    PMID: 41338335
  77. 77

    Sporadic Diffuse Palmoplantar Keratoderma in a Pediatric Patient With Early Onset: A Case Report.

    Premkumar L, Preethi P S, Swaminathan A, Sundaram M

    Cureus 2025; (17(12)):e100318 doi:10.7759/cureus.100318.

    PMID: 41613660
  78. 78

    Imaging Naxos disease and related cardiocutaneous syndromes: the NAXCARE multimodality approach.

    Protonotarios I, Alsergani H, Anastasakis A, et al.

    Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2026; doi:10.1016/j.hjc.2026.03.007.

    PMID: 41936932
  79. 79

    Physical Activity in Arrhythmogenic Cardiomyopathy: From Trigger to Therapeutic Dilemma.

    Kayvanpour E, Meder B, Sedaghat-Hamedani F

    Reviews in cardiovascular medicine 2026; (27(8)):52871 doi:10.31083/RCM52871.

    PMID: 42694556
  80. 80

    Naxos disease: current insights from early clinical observations to genetics and precision medicine.

    Xylouri Z, Al-Sergani H, Protonotarios I, et al.

    Internal and emergency medicine 2026; doi:10.1007/s11739-026-04559-9.

    PMID: 42932075